LU-001i is a highly specific proteasome beta1i (LMP2) inhibitor. LU-001i alone has no significant immunomodulatory effect, but when combined with the LMP7 inhibitor (PRN1126), it can exert anti-inflammatory and immunomodulatory effects. LU-001i can be used for the study of autoimmune diseases[1].
Molekulargewicht:
611.68
CAS Nummer:
[1620107-60-9]
Formel:
C28H43F2N7O6
Target-Kategorie:
Proteasome
Anwendungsbeschreibung:
MCE Product type: Reference compound
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
